GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,581,000 | -61.6% | 179,806 | -47.2% | 0.04% | -58.6% |
| Q2 2021 | $11,922,000 | -67.0% | 340,432 | -61.6% | 0.09% | -68.1% |
| Q1 2021 | $36,117,000 | +520.5% | 886,300 | +861.3% | 0.27% | +425.0% |
| Q2 2020 | $5,821,000 | +115.5% | 92,201 | +74.4% | 0.05% | +73.3% |
| Q1 2020 | $2,701,000 | -74.6% | 52,859 | -60.6% | 0.03% | -62.0% |
| Q4 2019 | $10,652,000 | +258.8% | 134,000 | +119.0% | 0.08% | +243.5% |
| Q3 2019 | $2,969,000 | -10.8% | 61,184 | -3.3% | 0.02% | -8.0% |
| Q2 2019 | $3,328,000 | -64.1% | 63,268 | -67.0% | 0.02% | -62.7% |
| Q1 2018 | $9,268,000 | – | 191,890 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 383,702 | $14,581,000 | 7.71% |
| Perceptive Advisors | 5,148,910 | $195,658,000 | 5.23% |
| Grace Capital | 312,514 | $11,876,000 | 4.65% |
| NEXTHERA CAPITAL LP | 549,231 | $20,871,000 | 4.00% |
| Asymmetry Capital Management, L.P. | 103,449 | $3,931,000 | 3.63% |
| Camber Capital Management LP | 2,075,000 | $78,850,000 | 3.37% |
| Casdin Capital, LLC | 440,000 | $16,720,000 | 2.03% |
| EMORY UNIVERSITY | 53,951 | $2,050,000 | 1.34% |
| ArchPoint Investors | 129,435 | $4,919,000 | 1.34% |
| Ghost Tree Capital, LLC | 150,000 | $5,700,000 | 1.21% |